Parameter
| Biomarker | GAD65 Ab | Full name | GAD65 antibody | Molecular Type | Antibodies (proteins) |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Susceptibility to diagnose, |
| Disease | Diabetes Mellitus | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Serum (ELISA, electrochemical luminescence method) | ||
| Pathobiological Mechanisms | Autoimmune antibodies against pancreatic beta cells, leading to insulin secretion defects | ||||
| Clinical Availability Status | Clinical routine classification diagnosis for T1DM and LADA, high-risk groups preferred antibody screening index | ||||
| Notes and Dynamics | Key core autoantibodies in type 1 diabetes, LADA diagnosis markers, used in high-risk population screening | ||||